Mednet Logo
HomeGastroenterology
Gastroenterology

Gastroenterology

Expert perspectives on IBD, liver disease, motility disorders, and GI diagnostic and therapeutic procedures.

Recent Discussions

Do you take any special considerations for a patient with ESKD who has an ileostomy/colostomy and wishes to start peritoneal dialysis?

1
2 Answers

Mednet Member
Mednet Member
Nephrology · Rush Medical College

My special considerations are to probably avoid PD. But it depends on what the surgical history was for that ileostomy or colostomy, e.g., there may be a lot of scar tissue. When PD works (flows easily in and out), it works; when it doesn',t it doesn't and if doesn't it usually doesn't get better (4...

Do you routinely perform serologic testing for systemic sclerosis when absent contractility is identified on high-resolution manometry?

1 Answers

Mednet Member
Mednet Member
Gastroenterology · University of South Florida

This is a good question. The first thing to consider is the LES pressure. If a patient has elevated LES relaxation pressure on high-resolution esophageal manometry, in combination with absent contractility, then this would be concerning for achalasia type 1 (especially when a patient also has delaye...

How do you counsel patients on the use of compounded weight loss medications?

2
3 Answers

Mednet Member
Mednet Member
Endocrinology · Michigan State University College of Human Medicine

It is a difficult question that is being asked more frequently, recently, because of the shortage of these drugs. I handle it the same way that I used to handle when patients asked about the use of herbs as food supplements. The important fact is that we don't know the reliability of these products....

Are there any biomarkers that might indicate who might be responders to atezolizumab/bevacizumab for HCC?

2 Answers

Mednet Member
Mednet Member
Medical Oncology · University of Texas MD Anderson Cancer Center

Not at this time. Some preliminary studies are being done as ad hoc at this point and was not pre specified before the IMbrave study launching

How many days prior to elective major surgery do you recommend holding oral GLP 1 R agonist therapy?

3
4 Answers

Mednet Member
Mednet Member
Endocrinology · UCSF - Fresno

Zero. Or, I suppose, if you're having surgery early in the morning, one.This has gone back and forth, but the most recent guidance from the ASA (with other societies concurring) has been that most patients can continue their GLP medications as normal preoperatively, with higher-risk people being rec...

When do you consider de-escalating therapy such as dupilumab in eosinophilic esophagitis?

1 Answers

Mednet Member
Mednet Member
Gastroenterology · University of South Florida

It is first important to recognize that EoE is a chronic condition. In a patient whose EoE is successfully being treated (whether it be with PPI therapy, swallowed steroids, food elimination, or dupilumab), the disease will invariably become active again over time if therapy is stopped. This is why ...

Do you avoid terlipressin for patients with hepatorenal syndrome who have an elevated bilirubin level?

2 Answers

Mednet Member
Mednet Member
Nephrology · The University of Texas Health Science Center at San Antonio

The CONFIRM trial excluded patients with Grade 3 acute on chronic liver failure (due to increased risk of pulmonary complications). There have also been concerns raised that using terlipressin on liver transplant candidates might improve their MELD score enough to jeopardize their spot on the waitin...

How do people approach non-HIV patients with hepatitis B, a negative Hepatitis B E antigen, normal LFTs and relatively low HBV DNA between 2000-20000?

5
2 Answers

Mednet Member
Mednet Member
Infectious Disease · Zucker School of Medicine at Hofstra / Northwell

Treatment of chronic Hep B is recommended to prevent maternal-fetal transmission, reactivation during chemotherapy, recurrence after liver transplantation, and in patients with decompensated cirrhosis. Treatment has been shown to reverse fibrosis and cirrhosis. Specifically referring to the above sc...

How do you approach dosing beta blockers for variceal prophylaxis when the standard dose doesn’t achieve the target heart rate?"

1
1 Answers

Mednet Member
Mednet Member
Hepatology · Northwestern

The question is obsolete, actually, as the preferred beta-blocker for variceal prophylaxis is now carvedilol per AASLD guidelines as of 2024. Carvedilol is preferred given more optimal lowering of portal pressure as well as data supporting reduced risk of decompensation. Carvedilol is not titrated t...

Can fatty liver disease present with elevations in alkaline phosphatase without other liver enzyme elevations (AST and ALT)?

2
1 Answers

Mednet Member
Mednet Member
Hepatology · Mount Sinai Hospital

It is very atypical but can occur. Patients usually have elevations in aminotransferases (usually ALT higher than AST) and there can be very mild concurrent elevations in alkaline phosphatase. An isolated alkaline phosphatase elevation should however prompt a more extensive serological work up as we...